Phosphodiesterase 3 (PDE3): Structure, localization and function

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 7, Issue 3, 2009, Pages 206-211

  Murata, Taku ^a   Shimizu, Kasumi ^a   Hiramoto, Kenichi ^a   Tagawa, Toshiro ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Heart; Malignant tumor; Phosphodiesterase 3 or PDE 3; Phosphodiesterase or PDE; Platelet; Salivary gland

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; CILOSTAMIDE; CILOSTAZOL; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; MILRINONE; PACLITAXEL; PHOSPHODIESTERASE III; PHOSPHODIESTERASE III INHIBITOR; ROLIPRAM; THAPSIGARGIN; TREQUINSIN; VINPOCETINE;

ASPIRATION PNEUMONIA; BRAIN INFARCTION; CANCER CELL; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL TRIAL; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME STRUCTURE; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE CELL; HUMAN; LIVER METASTASIS; MOLECULAR BIOLOGY; MULTIGENE FAMILY; NONHUMAN; OOCYTE MATURATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SALIVARY GLAND; THROMBOCYTE AGGREGATION; TISSUE SPECIFICITY;

ANIMALS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; GENE EXPRESSION; HEART; HUMANS; MYOCARDIUM; NEOPLASMS; OOCYTES; SALIVARY GLANDS;

EID: 70349498388     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152509789105453     Document Type: Review

References (73)

1. Manganiello, V.C.; Degerman, E. Cyclic nucleotide phosphodiesterases (PDEs): Diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents. Thromb. Haemost., 1999, 82, 407.
2. Degerman, E.; Belfrage, P.; Manganiello, V.C. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J. Biol. Chem., 1997, 272, 6823.
3. Shakur, Y.; Holst, L.S.; Landstrom, T.R.; Movsesian, M.; Degerman, E.; Manganiello, V. Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family. Prog. Nucleic Acid Res. Mol. Biol., 2001, 66, 241.
4. Francis, S.H.; Turko, I.V.; Corbin, J.D. Cyclic nucleotide phosphodiesterases: relating structure and function. Prog. Nucleic Acid Res. Mol. Biol., 2001, 65, 1.
5. Manganiello, V. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized. Mol. Pharmacol., 2003, 63, 1209.
6. Degerman, E.; Belfrage, P.; Newman, A.H.; Rice, K.C.; Manganiello, V.C. Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand. J. Biol. Chem., 1987, 262, 5797.
7. Boyes, S.; Loten, E.G. Purification of an insulin-sensitive cyclic AMP phosphodiesterase from rat liver. Eur. J. Biochem., 1988, 174, 303.
8. Degerman, E.; Moos, M., Jr.; Rascon, A.; Vasta, V.; Meacci, E.; Smith, C.J.; Lindgren, S.; Andersson, K.E.; Belfrage, P.; Manganiello, V. Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase. Biochim. Biophys. Acta, 1994, 1205, 189.
9. Manganiello, V.C.; Murata, T.; Taira, M.; Belfrage, P.; Degerman, E. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch. Biochem. Biophys., 1995, 322, 1.
10. Manganiello, V.C.; Taira, M.; Degerman, E.; Belfrage, P. Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). Cell Signal, 1995, 7, 445.
11. Zmuda-Trzebiatowska, E.; Oknianska, A.; Manganiello, V.; Degerman, E. Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes. Cell Signal, 2006, 18, 382.
12. Yamamoto, T.; Lieberman, F.; Osborne, J.C.Jr.; Manganiello, V.C.; Vaughan, M.; Hidaka, H. Selective inhibition of two soluble adenosine cyclic 3′,5′-phosphate phosphodiesterases partially purified from calf liver. Biochemistry, 1984, 23, 670.
13. Meacci, E.; Taira, M.; Moos, M.Jr.; Smith, C.J.; Movsesian, M.A.; Degerman, E.; Belfrage. P.; Manganiello, V. Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. Proc. Natl. Acad. Sci. USA, 1992, 89, 3721.
14. Taira, M.; Hockman, S.C.; Calvo, J.C.; Taira, M.; Belfrage, P.; Manganiello, V.C. Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. J. Biol. Chem., 1993, 268, 18573.
15. Miki, T.; Taira, M.; Hockman, S.; Shimada, F.; Lieman, J.; Napolitano, M.; Ward, D.; Taira, M.; Makino, H.; Manganiello, V.C. Characterization of the cDNA and gene encoding human PDE3B, the cGIP1 isoform of the human cyclic GMP-inhibited cyclic nucleotide phosphodiesterase family. Genomics, 1996, 36, 476.
16. Lobbert, R.W.; Winterpacht, A.; Seipel, B.; Zabel, B.U. Molecular cloning and chromosomal assignment of the human homologue of the rat cGMP-inhibited phosphodiesterase 1 (PDE3A) - a gene involved in fat metabolism located at 11p 15.1. Genomics, 1996, 37, 211.
17. Kasuya, J.; Liang, S.J.; Goko, H.; Park, S.H.; Kato, K.; Xu, Z.D.; Hockman, S.; Manganiello, V.C.; Fujita-Yamaguchi, Y. Cardiac type cGMP-inhibited phosphodiesterase (PDE3A) gene structure: similarity and difference to adipocyte type PDE3B gene. Biochem. Biophys. Res. Commun., 2000, 268, 827.
18. Rahn, T.; Ronnstrand, L.; Leroy, M.J.; Wernstedt, C.; Tornqvist, H.; Manganiello, V.C.; Belfrage, P.; Degerman, E. Identification of the site in the cGMP-inhibited phosphodiesterase phosphorylated in adipocytes in response to insulin and isoproterenol. J. Biol. Chem., 1996, 271, 11575.
19. Ahmad, F.; Cong, L.N.; Stenson Holst, L.; Wang, L.M.; Rahn Landstrom, T.; Pierce, J.H.; Quon, M.J.; Degerman, E.; Manganiello, V.C. Cyclic nucleotide phosphodiesterase 3B is a downstream target of protein kinase B and may be involved in regulation of effects of protein kinase B on thymidine incorporation in FDCP2 cells. J. Immunol., 2000, 164, 4678.
20. Kitamura, T.; Kitamura, Y.; Kuroda, S.; Hino, Y.; Ando, M.; Kotani, K.; Konishi, H.; Matsuzaki, H.; Kikkawa, U.; Ogawa, W.; Kasuga, M. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol. Cell Biol., 1999, 19, 6286.
21. Reinhardt, R.R.; Chin, E.; Zhou, J.; Taira, M.; Murata, T.; Manganiello, V.C.; Bondy, C.A. Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases. J. Clin. Invest., 1995, 95, 1528.
22. Elks, M.L.; Manganiello, V.C.; Vaughan, M. Effect of dexamethasone on adenosine 3′,5′-monophosphate content and phosphodiesterase activities in 3T3-L1 adipocytes. Endocrinology, 1984, 115, 1350.
23. Sun, B.; Li, H.; Shakur, Y.: Hensley, J.: Hockman, S.; Kambayashi, J.; Manganiello, V.C.; Liu, Y. Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice. Cell Signal, 2007, 19, 1765.
24. Netherton, S.J.; Maurice, D.H. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Mol. Pharmacol., 2005, 67, 263.
25. Ekholm, D.; Hemmer, B.; Gao, G.; Vergelli, M.; Martin, R.; Manganiello, V. Differential expression of cyclic nucleotide phosphodiesterase 3 and 4 activities in human T cell clones specific for myelin basic protein. J. Immunol., 1997, 159, 1520.
26. Murata, T.; Taira, M.; Manganiello, V.C. Differential expression of cGMP-inhibited cyclic nucleotide phosphodiesterases in human hepatoma cell lines. FEBS Lett., 1996, 390, 29.
27. Nagaoka, T.; Shirakawa, T.; Kasuya, J.; Balon, T.W.; Manganiello, V.C.; Fujita-Yamaguchi, Y. Cyclic nucleotide PDE-3. Quantitation of PDE-3A and -3B mRNAs in rat tissues by RNase protection assay. Cell Biochem, Biophys., 1998, 29, 49.
28. Liu, H.; Maurice, D.H. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP. Br. J. Phamacol., 1998, 125. 1501.
29. Grant, P.G.; Colman, R.W. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry, 1984, 23, 1801.
30. Smith, C.J.; Krall, J.; Manganiello, V.C.; Movsesian, M.A. Cytosolic and sarcoplasmic reticulum-associated low Km, cGMP-inhibited cAMP phosphodiesterase in mammalian myocardium. Biochem. Biophys. Res. Commun., 1993, 190, 516.
31. Leroy, M.J.; Degerman, E.; Taira, M.; Murata, T.; Wang, L.H.; Movsesian, M.A.; Meacci, E.; Manganiello, V.C. Characterization of two recombinant PDE3 (cGMP-inhibited cyclic nucleotide phosphodiesterase) isoforms, RcGIP1 and HcGIP2, expressed in NIH 3006 murine fibroblasts and Sf9 insect cells. Biochemistry, 1996, 35, 10194.
32. Kenan, Y.; Murata, T.; Shaku, Y.; Degerman, E..; Manganiello, V.C. Functions of the N-terminal region of cyclic nucleotide phosphodiesterase 3 (PDE 3) isoforms. J. Biol. Chem., 2000, 275, 12331.
33. Movsesian, M.A.; Komas, N.; Krall, J.; Manganiello, V.C. Expression and activity of low Km, cGMP-inhibited cAMP phosphodiesterase in cardiac and skeletal muscle. Biochem. Biophys. Res. Commun., 1996, 225, 1058.
34. Wechsler, J.; Choi, Y.H.; Krall, J.; Ahmad, F.; Manganiello, V.C.; Movsesian, M.A. Isoforms of cyclic nucleotide phosphodiesterase PDE3A in cardiac myocytes. J. Biol. Chem., 2002, 277, 38072.
35. Movsesian, M.A. Cyclic AMP-mediated signal transduction in heart failure: molecular pathophysiology and therapeutic implications. J. Investig. Med., 1997, 45, 432.
36. Baim, D.S.; McDowell, A.V.; Cherniles, J.; Monrad, E.S.; Parker, J.A.; Edelson, J.; Braunwald, E.; Grossman, W. Evaluation of a new bipyridine inotropic agent - milrinone - in patients with severe congestive heart failure. N. Engl. J. Med., 1983, 309, 748.
37. Jaski, B.E.; Fifer, M.A.; Wright, R.F.; Braunwald, E.; Colucci, W.S. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. J. Clin. Invest., 1985, 75, 643.
38. Massie, B.; Bourassa, M.; DiBianco, R.; Hess, M.; Konstam, M.; Likoff, M.; Packer, M. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. Circulation, 1985, 71, 963.
39. Uretsky, B.F.; Jessup, M.; Konstam, M.A.; Dec, G.W.; Leier, C.V.; Benotti, J.; Murali, S.; Herrmann, H.C.; Sandberg, J.A. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Circulation, 1990, 82, 774.
40. Drees, M.; Zimmermann, R.; Eisenbrand, G. 3′,5′-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition. Cancer Res., 1993, 53, 3058.
41. Murata, T.; Sugatani, T.; Shimizu, K.; Manganiello, V.C.; Tagawa, T. Phosphodiesterase 3 as a potential target for therapy of malignant tumors in the submandibular gland. Anticancer Drugs, 2001, 12, 79.
42. Shimizu, K.; Murata, T.; Okumura, K.; Manganiello, V.C.; Tagawa T. Expression and role of phosphodiesterase 3 in human squamous cell carcinoma KB cells. Anticancer Drugs, 2002, 13, 875.
43. Murata, T.; Shimizu, K.; Narita, M.; Manganiello, V.C.; Tagawa, T. Characterization of phosphodiesterase 3 in human malignant melanoma cell line. Anticancer Res., 2002, 22, 3171.
44. Pan, X.; Arauz, E.; Krzanowski, J.J.; Fitzpatrick, D.F.; Polson, J.B. Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells. Biochem. Pharmacol., 1994, 48, 827.
45. Karpatkin, S.; Pearlstein, E. Role of platelets in tumor cell metastases. Ann. Intern. Med., 1981, 95, 636.
46. Inufusa, H.; Adachi, T.; Nakamura, M.; Shindo, K.; Yasutomi, M.; Kimura, Y. Inhibition of experimental metastasis of human adenocarcinoma by cilostazol, a platelet phosphodiesterase inhibitor. Oncol. Rep., 1995, 2, 1079.
47. Ikeda, Y.; Matsumata, T.; Takenaka, K.; Yamagat, M.; Sugimachi, K. Effects of doxorubicin and/or cilostazol on cancer cells during liver regeneration after two-thirds hepatectomy in rats. Oncology, 1998, 55, 354.
48. Sutton, P.; Beaver, J.; Waring, P. Evidence that gliotoxin enhances lymphocyte activation and induces apoptosis by effects on cyclic AMP levels. Biochem. Pharmacol., 1995, 50, 2009.
49. McConkey, D.J.; Orrenius, S.; Jondal, M. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J. Immunol., 1990, 145, 1227.
50. McConkey, D.J.; Orrenius, S.; Okret, S.; Jondal, M. Cyclic AMP potentiates glucocorticoid-induced endogenous endonuclease activation in thymocytes. FASEB J., 1993, 7, 580.
51. Lalli, E.; Sassone-Corsi, P.; Ceredig R. Block of T lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathway. EMBO J., 1996, 15, 528.
52. Aharoni, D.; Dantes, A.; Oren, M.; Amsterdam, A. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells. Exp. Cell Res., 1995, 218, 271.
53. Rossi, A.G.; Cousin, J.M.; Dransfield, I.; Lawson, M.F.; Chilvers, E.R.; Haslett, C. Agents that elevate cAMP inhibit human neutrophil apoptosis. Biochem. Biophys. Res. Commun., 1995, 217, 892.
54. D'Mello, S.R.; Galli, C.; Ciotti, T.; Calissano, P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA, 1993, 90, 10989.
55. Mentz, F.; Mossalayi, M.D.; Ouaaz, F.; Baudet, S.; Issal, F.; Ktorza, S.; Semichon, M.; Binet, J.L.; Merle-Beral, H. Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood, 1996, 88, 2172.
56. Jiang, X.; Li, J.; Paskind, M.; Epstein, P.M. Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells. Proc. Natl. Acad. Sci. USA, 1996, 93, 11236.
57. Moon, E.; Lee, R.; Near, R.; Weintraub, L.; Wolda. S.; Lerner, A. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia. Clin. Cancer Res., 2002, 8, 589.
58. Zhu, W.H.; Majluf-Cruz, A.; Omburo, G.A. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism. Life Sci., 1998, 63, 265.
59. Ferguson, D.B. In Color Atlas and Text of the Salivary Glands Diseases, Disorders and Surgery; Norman, J.E.; McGurk, M. Eds.; Mosby-Wolfe: London, 1995, pp.40-48.
60. Zhang, G.H.; Martinez, J.R. Effects of forksolin, dibutyryl cAMP and H89 on Ca2+ mobilization in submandibular salivary cells of newborn rats. Arch. Oral Biol., 1999, 44, 735.
61. Imai, A.; Nashida, T.; Shimomura, H. Regulation of cAMP phosphodiesterases by cyclic nucleotides in rat parotid gland. Biochem. Mol. Biol. Int., 1995, 37, 1029.
62. Imai, A.; Nashida, T.; Shimomura. H. Characterization of cyclic AMP phosphodiesterase isozymes in rat parotid gland. Arch. Oral Biol., 1995, 40, 165.
63. Imai, A.; Nashida, T.; Shimomura, H. Comparison of phosphodiesterase isozymes in rodent parotid glands. Comp. Biochem. Physiol. Biochem. Mol. Biol., 1999, 124, 397.
64. Tanaka, S.; Shimooka, S.; Shimomura, H. Changes in phosphodiesterase activity in the developing rat submandibular gland. Arch. Oral Biol., 2002, 47, 567.
65. Murata, T.; Sugatani, T.; Tagawa, T. Expression of phosphodiesterase 3 in rat submandibular gland. Arch. Oral Biol. 2000, 45, 1043.
66. Murata, T.; Sugatani, T.; Manganiello, V.C.; Shimizu, K.; Tagawa, T. Expression of phosphodiesterase 3 in rat submandibular gland cell lines. Arch. Oral Biol., 2001, 46, 453.
67. Shimizu, K.; Murata, T.; Hiramoto, K.; Sugiyama, T.; Nakagawa, T.; Manganiello, V.C.; Tagawa, T. Expression of cyclic nucleotide phosphodiesterase 3A in isolated rat submandibular acini. Arch. Oral Biol., 2006, 51, 83.
68. He, X.J.; Frank, D.P.; Tabak, L.A. Establishment and characterization of 12S adenoviral E1A immortalized rat submandibular gland epithelial cells. Biochem. Biophys. Res. Commun., 1990, 170, 336.
69. He, X.; Kuijpers, G.A.; Goping. G.; Kulakusky, J.A.; Zheng, C.; Delporte, C.; Tse, C.M.; Redman, R.S.; Donowitz, M.; Pollard, H.B.; Baum, B.J. A polarized salivary cell monolayer useful for studying transepithelial fluid movement in vitro. Pflugers Arch., 1998, 435, 375.
70. Nehrke, K.; Tabak, L.A. Biosynthesis of a low-molecular-mass rat submandibular gland mucin glycoprotein in COS7 cells. Biochem. J., 1997, 323, 497.
71. Albone, E.F.; Hagen, F.K.; VanWuyckhuyse, B.C.; Tabak, L.A. Molecular cloning of a rat submandibular gland apomucin. J. Biol. Chem., 1994, 269, 16845.
72. Loeb, M.B.; Becker, M; Eady, A.; Walker-Dilks, C. Interventions to prevent aspiration pneumonia in older adults: a systematic review. J. Am. Geriatr. Soc., 2003, 51, 1018.
73. Masciarelli, S.; Horner, K.; Liu, C.; Park, S.H.; Hinckley, M.; Hockman, S.; Nedachi, T.; Jin, C.; Conti, M.; Manganiello, V.J. Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of female infertility. J. Clin. Invest., 2004, 114, 196.